Karl Balabanian to visit Armenia for Collaborative Engagements in Immunotherapy and Oncology Research – Immune Oncology Research Institute

Immune Oncology Research Institute shared a post on LinkedIn:

”Great news!

We are excited to share that this October, Dr. Karl Balabanian, Research Director at INSERM and leader of the ‘Chemokines, Lymphoid Niches and Immunopathology’ team at Saint-Louis Hospital and the INSERM U1160 unit, will be visiting Armenia. During his visit, he will engage with the teams at the Immune Oncology Research Institute and the Yeolyan Hematology and Oncology Center.”

Read further.
Source: Immune Oncology Research Institute/LinkedIn